title: Selective activation by photodynamic action of cholecystokinin receptor in the freshly isolated rat pancreatic acini.
abstract: 1 Sulphonated aluminium phthalocyanine (SALPC) photodynamic action induces amylase secretion and permanent calcium oscillation in rat pancreatic acinar cells, because of the activation of phospholipase C or signalling proteins upstream. The aim of the present study was to investigate the involvement of muscarinic acetylcholine and cholecystokinin (CCK) receptors. 2 Muscarinic receptor antagonist atropine (10 micro M) blocked amylase secretion induced by bethanechol (100 micro M), and CCK(1) receptor antagonist (S)-N-[1-(2-fluorophenyl)-3,4,6,7-tetrahydor-4-oxo-pyrrolo-[3,2,1-jk][1,4] benzodiazepine-3yl]-1H-indole-2-carboxamide (FK480) (1 micro M) blocked amylase secretion induced by CCK (100 pM). 3 Amylase secretion induced by SALPC photodynamic action was not inhibited when atropine and FK480 were present during photodynamic action. However, addition of FK480 1 micro M after initiation of photodynamic action inhibited photodynamic amylase secretion. Bethanechol (10, 100 micro M) added after photodynamic action resulted in a full secretory response. 4 Atropine (10 nM) abolished calcium oscillation induced by bethanechol (5 micro M), and FK480 (10 nM) blocked calcium oscillation induced by CCK (10 pM). 5 Atropine up to 10 micro M was without effect on Ca(2+) oscillation triggered by photodynamic action, but these oscillations were abolished by FK480 (10 nM). FK480 (10 nM) had no effect on calcium oscillations induced by bethanechol (5 micro M). Bethanechol 5 micro M, added after FK480 blockade of photodynamic calcium oscillation, still triggered regular calcium oscillation. 6 It is concluded that SALPC photodynamic action selectively and permanently activates CCK receptor in rat pancreatic acini. Such permanent and selective modulation of signalling proteins has important implications for the treatment of pancreatitis, prion diseases, and neurodegenerative disorders.
authors.affiliation: Institute of Cell Biology, Beijing Normal University, Beijing 100875, China.
authors.forename: Yu Ping
authors.initials: YP
authors.lastname: An
authors.forename: Rui
authors.initials: R
authors.lastname: Xiao
authors.forename: Hong
authors.initials: H
authors.lastname: Cui
authors.forename: Zong Jie
authors.initials: ZJ
authors.lastname: Cui
mesh_terms: D000681:Amylases / Q000037:antagonists & inhibitors / Q000378:metabolism; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology; D018723:Bethanechol / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002766:Cholecystokinin / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D008027:Light; D009942:Organometallic Compounds / Q000494:pharmacology; D010179:Pancreas / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D010778:Photochemotherapy; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors / Q000187:drug effects* / Q000378:metabolism*; D011976:Receptors, Muscarinic / Q000187:drug effects
chemical_list: D001570:Benzodiazepinones; D007211:Indoles; D009942:Organometallic Compounds; D011949:Receptors, Cholecystokinin; D011976:Receptors, Muscarinic; D018723:Bethanechol; C082966:FR 120480; C060570:aluminum phthalocyanine; D001285:Atropine; D002766:Cholecystokinin; D000681:Amylases; D002118:Calcium